Liquid Biopsy Market Share, Types, Applications, Products, Size, Growth, Insights and Forecasts Report 2027

liquid biopsy market size is expected to reach USD 5.53 Billion in 2028 and register a steady revenue CAGR of 20.8% during the forecast period, according to latest analysis by Emergen Research. Rise in demand for early detection of cancer is a key factor driving global liquid biopsy market revenue growth.

Liquid biopsy is a safe and popular procedure carried out during examination of cancer. The procedure is easy and minimally invasive, allows early detection and diagnosis of cancer, and helps in identification of cancer treatment. Surge in preference for non-invasive procedures is driving private and public funding to support research activities in the liquid biopsy field. Liquid biopsies allow medical professional to discover various aspects of a tumor through a patient’s blood sample. It facilitates medical professionals to understand which treatments are suitable for which patients.

Liquid Biopsy Market research report is a detailed document outlining the recent advancements and developments in the Liquid Biopsy business sphere considering 2020 as the base year and 2021-2027 as the forecast timeline. The report offers valuable insights into the market size, market share, sales channel and distribution network, segmentation of the market, demands, and trends, and growth prospects. The report also studies the growth of the market on a global and regional scale.

Claim Your FREE Sample Copy with Table of [email protected] https://www.emergenresearch.com/request-sample/34

The report offers a complete analysis of the global Liquid Biopsy market on a global and regional scale and offers a forecast for the market for 8 years. The report provides extensive coverage of the market drivers, restraints, limitations, growth prospects, threats, opportunities, and current and emerging trends in the market. The report also offers an in-depth analysis of the market players along with their business overview, product portfolio, technological advancements, expansion plans, financial standing, and global position. It also sheds light on the collaborations in the competitive landscape, such as mergers and acquisitions, joint ventures, collaborations, product launches, brand promotions, corporate and government deals, licensing agreements, and others.

Key companies profiled in the report include:

Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Inc., RainDance Technologies, Inc., Biocept, Inc., Qiagen N.V., Trovagene, Inc., and F. Hoffmann-La Roche Ltd.

The report further covers comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a complete understanding of the competitive landscape and scenario of each market player. The report also provides an in-depth analysis of the applications and product types offered in the market.

Emergen Research has segmented the global liquid biopsy market on the basis of product, circulating biomarkers, sample type, disease, application, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2018–2028)
    • Assays Kits
    • Instruments
    • Services
  • Circulating Biomarkers Outlook (Revenue, USD Billion; 2018–2028)
    • Circulating Tumor DNA (ctDNA)
    • Circulating Tumor Cells (CTCs)
    • Extracellular Vesicles (EVs)
    • Cell-Free DNA (cfDNA)
    • Other Circulating Biomarkers
  • Sample Type Outlook (Revenue, USD Billion; 2018–2028)
    • Blood Sample based
    • Urine Sample based
    • Other Bio Fluids based
  • Disease Outlook (Revenue, USD Billion; 2018–2028)
    • Oncology
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Colorectal Cancer
      5. Melanoma Cancer
      6. Other Cancers
    • Non-cancer disease
  • Application Outlook (Revenue, USD Billion; 2018–2028)
    • Early Cancer Screening
    • Therapy Selection
    • Treatment Monitoring
    • Recurrence Monitoring Orthopedics
  • End-use Outlook (Revenue, USD Billion; 2018–2028)
    • Hospitals and Physician Laboratories
    • Reference Laboratories
    • Academic and Research Centers
    • Others

Regional Analysis:

Regional analysis includes an in-depth study of the key geographical regions to gain a better understanding of the market and provide an accurate analysis. The regional analysis covers North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The regional analysis covers the analysis of key market segments, including revenue, CAGR, import/export, supply and demand ratio, production and consumption ratio, industrial chain analysis, and market dynamics in each region of the geographies.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type & applications

Chapter 9: Current and Future Trends

Explore Similar Reports offered by Emergen Research

High-performance Liquid Chromatography (HPLC) Market Report- Forecast 2028

Flow Imaging Microscopy Market Research Report-Global Forecast Till 2028

Bioanalytical Testing Services Market Report- Forecast 2028

2D Chromatography Market Report- Forecast 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:                    

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

 

You may also like...

Leave a Reply

Your email address will not be published.